VERICI DX PLC Logo

VERICI DX PLC

VRCI | IL

Overview

Corporate Details

ISIN(s):
GB00BM8HZD43
LEI:
213800FI5WE4FVQ3G645
Country:
United Kingdom
Address:
AVON HOUSE, CF64 2EZ CARDIFF
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Verici Dx PLC is an immuno-diagnostics development company specializing in the kidney transplant market. The company develops and commercializes a suite of advanced prognostic and diagnostic tests that form a comprehensive kidney transplant platform. Leveraging artificial intelligence-assisted transcriptomic analysis, its technology deciphers RNA signatures to provide data-driven insights into the body's immune response. These tests offer personalized patient and organ response risk assessments to assist clinicians in medical management throughout the transplant process, from pre-transplant evaluation to late-stage monitoring. The core mission is to predict the risk of organ injury, rejection, and graft failure, ultimately improving patient outcomes and overall graft survival. The company also collaborates with biopharmaceutical and data science partners to foster innovation.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for VERICI DX PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-01 11:40
Major Shareholding Notification
Holding(s) in Company
English 51.2 KB
2025-07-31 18:28
Major Shareholding Notification
Holding(s) in Company
English 40.6 KB
2025-07-31 16:24
Major Shareholding Notification
Holding(s) in Company
English 52.9 KB
2025-07-31 08:00
Regulatory News Service
Tutivia™ abstracts for World Transplant Congress
English 15.3 KB
2025-07-30 15:32
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-07-30 15:26
Major Shareholding Notification
Holding(s) in Company
English 22.5 KB
2025-07-30 08:00
Post-Annual General Meeting Information
Result of Annual General Meeting
English 17.8 KB
2025-07-29 08:00
Share Issue/Capital Change
Result of WRAP Retail Offer
English 27.3 KB
2025-07-28 18:19
Major Shareholding Notification
Holding(s) in Company
English 53.2 KB
2025-07-28 17:55
Major Shareholding Notification
Holding(s) in Company
English 51.6 KB
2025-07-28 11:23
Major Shareholding Notification
Holding(s) in Company
English 22.9 KB
2025-07-25 18:22
Major Shareholding Notification
Holding(s) in Company
English 25.8 KB
2025-07-25 14:05
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-07-25 14:04
Major Shareholding Notification
Holding(s) in Company
English 40.6 KB
2025-07-22 08:00
Share Issue/Capital Change
WRAP Retail Offer for up to £500,000
English 33.2 KB

Automate Your Workflow. Get a real-time feed of all VERICI DX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VERICI DX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN